11th Advanced Forum on Biotech Patents


Brian Coggio (NY) is co-chair of this conference, and Janis Fraser (Boston) will speak on “Deciphering the Impact of In re Kubin on Application of 103 Obviousness Requirements” at the 11th Advanced Forum on Biotech Patents presented by the American Conference Institute.

Emerging from a turbulent year of new case law, a resurgence of the proposed PTO rules, uncertainty associated with a new administration, and tough economic conditions, biotech patent practitioners must prepare for a new phase in this ever-evolving field. And with groundbreaking legislation regarding patent reform and follow-on biologics on the horizon, patent counsel must rise to the challenge to overcome increasing rejections, promote innovation and maximize profitability.

With this in mind, ACI's 11th Advanced Forum on Biotech Patents once again brings together a high-caliber team of experienced biotech patent counsel who will share their collective knowledge and provide you with the most up to date strategies you can immediately incorporate into your practice. For more information, please visit http://www.americanconference.com/.